416 related articles for article (PubMed ID: 36497090)
21. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
Zhang J; Hu M; Teng Z; Tang YP; Chen C
J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
[TBL] [Abstract][Full Text] [Related]
22. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
23. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
Zhao J; O'Connor T; Vassar R
J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
[TBL] [Abstract][Full Text] [Related]
24. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
[TBL] [Abstract][Full Text] [Related]
25. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
[TBL] [Abstract][Full Text] [Related]
26. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.
Bettens K; Brouwers N; Engelborghs S; Van Miegroet H; De Deyn PP; Theuns J; Sleegers K; Van Broeckhoven C
Hum Mutat; 2009 Aug; 30(8):1207-13. PubMed ID: 19462468
[TBL] [Abstract][Full Text] [Related]
27. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
Sha S; Shen X; Cao Y; Qu L
Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
[TBL] [Abstract][Full Text] [Related]
29. Expression of amyloid-associated miRNAs in both the forebrain cortex and hippocampus of middle-aged rat.
Che H; Sun LH; Guo F; Niu HF; Su XL; Bao YN; Fu ZD; Liu HL; Hou X; Yang BF; Ai J
Cell Physiol Biochem; 2014; 33(1):11-22. PubMed ID: 24401368
[TBL] [Abstract][Full Text] [Related]
30. High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation.
Maesako M; Uemura M; Tashiro Y; Sasaki K; Watanabe K; Noda Y; Ueda K; Asada-Utsugi M; Kubota M; Okawa K; Ihara M; Shimohama S; Uemura K; Kinoshita A
PLoS One; 2015; 10(9):e0131199. PubMed ID: 26414661
[TBL] [Abstract][Full Text] [Related]
31. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
[TBL] [Abstract][Full Text] [Related]
32. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
33. Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing.
Wang Y; Cui Y; Liu J; Song Q; Cao M; Hou Y; Zhang X; Wang P
Alzheimers Res Ther; 2022 Jul; 14(1):103. PubMed ID: 35883144
[TBL] [Abstract][Full Text] [Related]
34. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
35. Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes.
Huang D; Yu M; Yang S; Lou D; Zhou W; Zheng L; Wang Z; Cai F; Zhou W; Li T; Song W
Mol Neurobiol; 2018 Jun; 55(6):5006-5018. PubMed ID: 28799137
[TBL] [Abstract][Full Text] [Related]
36. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
[TBL] [Abstract][Full Text] [Related]
37. Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing.
Zhao Y; Wang Y; Yang J; Wang X; Zhao Y; Zhang X; Zhang YW
Mol Neurodegener; 2012 Jun; 7():30. PubMed ID: 22709416
[TBL] [Abstract][Full Text] [Related]
38. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
Wang WX; Rajeev BW; Stromberg AJ; Ren N; Tang G; Huang Q; Rigoutsos I; Nelson PT
J Neurosci; 2008 Jan; 28(5):1213-23. PubMed ID: 18234899
[TBL] [Abstract][Full Text] [Related]
39. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
